Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial (Q35760193)
Jump to navigation
Jump to search
scientific article published on 17 November 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial |
scientific article published on 17 November 2006 |
Statements
1 reference
Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial (English)
1 reference
D D Gladman
1 reference
A Kavanaugh
1 reference
G G Krueger
1 reference
A Beutler
1 reference
C Guzzo
1 reference
B Zhou
1 reference
L T Dooley
1 reference
P J Mease
1 reference
K de Vlam
1 reference
P P Geusens
1 reference
C Birbara
1 reference
D G Halter
1 reference
C Antoni
1 reference
IMPACT 2 Study Group
1 reference
17 November 2006
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference